SCHEMBL8807951

SCHEMBL8807951

COc1ccc(CN(C)CCc2ccc(NC(=O)c3cccc4c(=O)c5ccccc5sc34)cc2)cc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KDM4E B2RXH2 5/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ ABCB1 P08183 3/20 0.43
▸ ABCG2 Q9UNQ0 3/20 0.43
▸ MAPT P10636 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ TMEM97 Q5BJF2 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ HCRTR1 O43613 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8809632 0.95 BCHE (0.44) BCHEACHEKMT2AMEN1KDM4E
SCHEMBL8808386 0.95 MAPT (0.45) BCHEACHEKMT2AMEN1KDM4E
SCHEMBL8809566 0.94 BCHE (0.43) BCHEACHEKMT2AMEN1KDM4E
SCHEMBL8808101 0.94 BCHE (0.43) BCHEACHEKMT2AMEN1KDM4E
SCHEMBL8807015 0.92 ABCG2 (0.44) KMT2AMEN1KDM4EALDH1A1CYP3A4
SCHEMBL8807050 0.92 ABCB1 (0.45) BCHEACHEKMT2AMEN1KDM4E
SCHEMBL8806933 0.91 KDM4E (0.42) BCHEACHEKMT2AMEN1KDM4E
SCHEMBL8810117 0.91 MCHR1 (0.45) BCHEACHEKMT2AMEN1KDM4E
SCHEMBL8808363 0.90 MAOA (0.46) BCHEACHEOPRM1TMEM97SIGMAR1
SCHEMBL8807954 0.89 F10 (0.43) KMT2AMEN1KDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback